Literature DB >> 10735621

Cross-genotypic interaction between hepatitis C virus NS3 protease domains and NS4A cofactors.

J Wright-Minogue1, N Yao, R Zhang, N J Butkiewicz, B M Baroudy, J Y Lau, Z Hong.   

Abstract

BACKGROUND/AIMS: Hepatitis C virus (HCV) nonstructural protein 3 (NS3) protease requires NS4A as a cofactor. This cofactor activity has been mapped to the central region of NS4A which interacts with the N-terminus of NS3 protease. To investigate whether this interaction is conserved among different genotypes of HCV cross-genotypic characterization were performed to delineate the importance of NS4A cofactor function in relation to the molecular evolution of HCV
METHODS: Active NS3 protease domains of genotype 1-3 (representing five subtypes: la, 1b, 2a, 2b and 3a) were produced and purified from bacterial cells. NS4A cofactor-dependent in vitro trans cleavage assays were established using the in vitro translated recombinant protein substrates. These substrates contained the junction site of NS4A/NS4B, NS4B/NS5A or NS5A/NS5B.
RESULTS: Our data revealed that NS3 proteases cross-interacted with NS4A cofactors derived from different genotypes, although the genotype 2 cofactor was less efficient, which could be due to greater genetic variations in this region. Furthermore, the corresponding region in hepatitis G virus (HGV) NS4A was found to provide weak cofactor activity for HCV NS3 protease. Surprisingly, a synthetic substrate peptide from the NS4B/NS5A junction was also found to enhance HCV NS3 protease activity in a dose-dependent manner.
CONCLUSION: Our study suggests that the NS4A cofactor function is well conserved among HCV It is likely that other HCV-related viruses may have developed similar strategies to regulate their protease activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10735621     DOI: 10.1016/s0168-8278(00)80402-x

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

1.  Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.

Authors:  N Butkiewicz; N Yao; W Zhong; J Wright-Minogue; P Ingravallo; R Zhang; J Durkin; D N Standring; B M Baroudy; D V Sangar; S M Lemon; J Y Lau; Z Hong
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Development of an intergenotypic hepatitis C virus (HCV) cell culture method to assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1 to 6.

Authors:  Ingrid Imhof; Peter Simmonds
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

3.  Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells.

Authors:  MinKyung Yi; Stanley M Lemon
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

4.  Sensitivity of NS3 serine proteases from hepatitis C virus genotypes 2 and 3 to the inhibitor BILN 2061.

Authors:  Diane Thibeault; Christiane Bousquet; Rock Gingras; Lisette Lagacé; Roger Maurice; Peter W White; Daniel Lamarre
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 5.  Post-translational modifications of hepatitis C viral proteins and their biological significance.

Authors:  Jana Hundt; Zhubing Li; Qiang Liu
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

6.  Stimulation of hepatitis C virus (HCV) nonstructural protein 3 (NS3) helicase activity by the NS3 protease domain and by HCV RNA-dependent RNA polymerase.

Authors:  Chen Zhang; Zhaohui Cai; Young-Chan Kim; Ranjith Kumar; Fenghua Yuan; Pei-Yong Shi; Cheng Kao; Guangxiang Luo
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.